In arguments about GLP-1 GI complications, one camp says 'it's all fear-mongering' and the other says 'everyone is getting gastroparesis,' but both can be inaccurate; the science to date shows that most people will not develop severe GI motility complications, but if you're vulnerable, this mechanism matters and prevention and close monitoring matters even more.

normativepending

Speaker

Dr. Amin Dadgar

Evidence Quote

“This is where sloppy internet arguments show up. One camp says, 'It's all fear-mongering.' The other camp says, 'Everyone is getting gastroparesis.' Both can be inaccurate, and the science to date shows that most people will not develop severe GI motility complications.”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...